|
GB202103126D0
|
|
Method of synthesising artificial proteins
|
|
GB202102420D0
|
|
Method and apparatus
|
|
GB202101274D0
|
|
Method of parallel implementation in distributed memory architectures
|
|
GB202100097D0
|
|
Novel composition
|
|
GB202019826D0
|
|
Improvements in electrochemical reduction of carbon dioxide
|
|
GB202019563D0
|
|
Appratus and method
|
|
GB202019005D0
|
|
Method of parallel implementation in dstributed memory architectures
|
|
GB202018940D0
|
|
Catalyst, apparatus and method
|
|
GB202018825D0
|
|
Composition and method
|
|
GB202017724D0
|
|
Pharmaceutically active compound formulations
|
|
GB202016847D0
|
|
Method, product and apparatus
|
|
GB202016603D0
|
|
Chemical conditions
|
|
GB202015810D0
|
|
Bacterial microcompartmental shells
|
|
GB202013946D0
|
|
Filter
|
|
GB202006473D0
|
|
Additive manufacturing components and methods
|
|
GB202006475D0
|
|
Additive manufacturing components and methods
|
|
GB202005492D0
|
|
Anti-infective agents
|
|
WO2020169511A1
|
|
Method of diagnosis
|
|
GB202002009D0
|
|
An imaging device
|
|
WO2020128525A1
|
|
Nrti therapies
|
